These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20352536)

  • 1. Polymer percolation threshold in HPMC extended release formulation of carbamazepine and verapamil HCl.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    AAPS PharmSciTech; 2010 Jun; 11(2):558-62. PubMed ID: 20352536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
    Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
    Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Jan; 41(1):70-8. PubMed ID: 24134563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer Percolation Threshold in Multi-Component HPMC Matrices Tablets.
    Maghsoodi M; Barghi L
    Adv Pharm Bull; 2011; 1(1):27-33. PubMed ID: 24312753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.
    Siepmann J; Kranz H; Bodmeier R; Peppas NA
    Pharm Res; 1999 Nov; 16(11):1748-56. PubMed ID: 10571282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
    Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic release of theophylline from hydrophilic swellable matrices.
    Vargas CI; Ghaly ES
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1045-50. PubMed ID: 10518245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Chem Pharm Bull (Tokyo); 2006 May; 54(5):598-602. PubMed ID: 16651752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release Adjustment of Two Drugs with Different Solubility Combined in a Matrix Tablet.
    Chaerunisaa AY; Ali R; Dashevskiy A
    AAPS PharmSciTech; 2019 Mar; 20(4):142. PubMed ID: 30874996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of drug release in citrate buffered HPMC matrices.
    Pygall SR; Kujawinski S; Timmins P; Melia CD
    Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity.
    Castellanos Gil E; Iraizoz Colarte A; Bataille B; Brouillet F; Caraballo I
    Eur J Pharm Sci; 2009 Nov; 38(4):312-9. PubMed ID: 19666114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New comprehensive mathematical model for HPMC-MCC based matrices to design oral controlled release systems.
    Saeidipour F; Mansourpour Z; Mortazavian E; Rafiee-Tehrani N; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2017 Dec; 121():61-72. PubMed ID: 28951063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
    Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
    Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.